Employment Verification for Iovance Biotherapeutics.

About Iovance Biotherapeutics

Iovance Biotherapeutics is a clinical-stage biotechnology company that develops and commercializes novel cancer immunotherapy products. Founded in 2007, Iovance’s mission is to improve the lives of cancer patients by developing safe, effective immunotherapies that enhance the body’s natural defenses against cancer. The company’s focus is on the development of adoptive cell therapy (ACT), a type of cancer immunotherapy that involves the isolation and modification of a patient’s own immune cells (T-cells) to target and destroy cancer cells. Iovance’s lead product candidate is lifileucel, a T-cell therapy for the treatment of advanced melanoma. The company is also developing product candidates for the treatment of other solid tumor types, including cervical, head and neck, and lung cancers. These product candidates are based on the same ACT technology platform as lifileucel and have shown promising results in early clinical trials. Iovance is headquartered in San Carlos, California, and has manufacturing and research facilities in The Netherlands. The company has partnerships with several leading cancer centers and academic institutions and has received support from the National Cancer Institute and other organizations. As of 2021, Iovance has a market capitalization of approximately $5 billion and employs over 500 people worldwide.

The information on this page is not an endorsement of Truv’s services by Iovance Biotherapeutics and is meant to be purely informational.

Verify Iovance Biotherapeutics Employees

Truv provides quick, secure and cost-effective employment and income verifications for thousands of verifiers. The process is simple and automated and most employees are verified in under 24 hours. You only pay for successful verification and can save on average 50% compared to competitors. Thousands of verifiers love Truv because it’s been never been easier and more streamlined to verify an employee, learn more.